Shopping Cart
Remove All
Your shopping cart is currently empty
Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $645 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,530 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection. |
| In vitro | Odesivimab, Atoltivimab and Maftivimab can be combined to form REGN-EB3 with an IC50 value of 0.39 nM, which can be used for Ebola virus research. Odesivimab showed specific binding to soluble viral glycoprotein. [1] |
| In vivo | Odesivimab with Atoltivimab and Maftivimab (REGN-3471, 50 mg/kg) were protective against Ebola virus infected rhesus monkey models. [1] |
| Synonyms | REGN-3471, REGN3471 |
| Reactivity | Virus |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2135632-30-1 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.